1. Home
  2. ACHL vs BEEM Comparison

ACHL vs BEEM Comparison

Compare ACHL & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • BEEM
  • Stock Information
  • Founded
  • ACHL 2016
  • BEEM 2006
  • Country
  • ACHL United Kingdom
  • BEEM United States
  • Employees
  • ACHL N/A
  • BEEM N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • BEEM Semiconductors
  • Sector
  • ACHL Health Care
  • BEEM Technology
  • Exchange
  • ACHL Nasdaq
  • BEEM Nasdaq
  • Market Cap
  • ACHL 46.8M
  • BEEM 49.3M
  • IPO Year
  • ACHL 2021
  • BEEM N/A
  • Fundamental
  • Price
  • ACHL $1.14
  • BEEM $3.03
  • Analyst Decision
  • ACHL Buy
  • BEEM Strong Buy
  • Analyst Count
  • ACHL 2
  • BEEM 4
  • Target Price
  • ACHL $4.00
  • BEEM $9.00
  • AVG Volume (30 Days)
  • ACHL 266.7K
  • BEEM 362.7K
  • Earning Date
  • ACHL 11-14-2024
  • BEEM 11-14-2024
  • Dividend Yield
  • ACHL N/A
  • BEEM N/A
  • EPS Growth
  • ACHL N/A
  • BEEM N/A
  • EPS
  • ACHL N/A
  • BEEM N/A
  • Revenue
  • ACHL N/A
  • BEEM $60,883,000.00
  • Revenue This Year
  • ACHL N/A
  • BEEM N/A
  • Revenue Next Year
  • ACHL N/A
  • BEEM $24.12
  • P/E Ratio
  • ACHL N/A
  • BEEM N/A
  • Revenue Growth
  • ACHL N/A
  • BEEM 10.25
  • 52 Week Low
  • ACHL $0.63
  • BEEM $2.62
  • 52 Week High
  • ACHL $1.76
  • BEEM $8.48
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 55.79
  • BEEM 43.75
  • Support Level
  • ACHL $1.12
  • BEEM $2.92
  • Resistance Level
  • ACHL $1.18
  • BEEM $3.31
  • Average True Range (ATR)
  • ACHL 0.05
  • BEEM 0.34
  • MACD
  • ACHL -0.00
  • BEEM 0.00
  • Stochastic Oscillator
  • ACHL 33.33
  • BEEM 10.28

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

Share on Social Networks: